Nuveen Churchill Direct Lending Corp. current report, 05 March 2024

Filing Summary

Business Context and Reporting Period

Nuveen Churchill Direct Lending Corp. filed a Form 8-K under Item 8.01, dated March 5, 2024, regarding adoption of a share repurchase plan. The company is a Maryland corporation with common stock listed on the NYSE under ticker NCDL.

Key Financial and Capital Markets Details

  • Repurchase authorization: Up to $99.275 million of common stock may be purchased in the open market.
  • Purchase price: Repurchases are generally required to occur at prices below the company’s most recently reported net asset value per share.
  • Agent: BofA Securities, Inc. will execute repurchases on the company’s behalf.
  • Duration: The plan becomes effective March 29, 2024 and generally terminates after 12 months, subject to suspension periods and earlier termination.
  • Financial metrics: The filing does not provide revenue, earnings, cash flow, margin, debt, liquidity, or current NAV figures.

Material Changes and Management Rationale

The company newly adopted a Rule 10b5-1 share repurchase plan. Management stated that repurchasing shares below NAV may be in the best interests of stockholders because it allows the company to reinvest in its portfolio.

Outlook, Conditions, and Risks

  • Repurchase activity will depend on the plan’s conditions, the market price of the stock, trading volumes, and applicable law.
  • The agent may increase purchase volume as the stock price declines, subject to volume restrictions.
  • No assurance is provided that any specific number or dollar amount of shares will be repurchased.
  • Purchases may be suspended or prohibited under insider-trading restrictions, Regulation M, Rule 10b-18, Rule 10b5-1, or other applicable requirements.
  • The plan terminates when the 12-month period ends, the aggregate purchase price reaches $99.275 million, or certain other specified events occur.

Investor Verification Items

  • Verify the company’s most recently reported NAV per share and any subsequent corrections or adjustments.
  • Monitor actual repurchases, remaining authorization, and the average prices paid.
  • Assess the stock’s market price relative to NAV and the effect of repurchases on NAV per share and portfolio capital.
  • Review the complete 10b5-1 plan for additional suspension and termination provisions.